arrow
Back
D

David S. Hong

department of investigational cancer therapeutics

104H-index
2.0KPaper Count
4.6WCitation Count
Published Papers 405
Publication Date
Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer
err2026-08-11
err0
errOAAI
errIda Aronchik; Sumit Kar; Yongxian Zhuang; Ethan Ahler; Lick Pui Lai; Vidya Seshadri; Yu Chi Yang; Ashenafi Bulle; Marie Menard; Biswadeep Nayak; Mark P. Labrecque; Julien Dilly; Eejung Kim; Lingyan Jiang; Jason Yano; Urszula N. Wasko; Ciara Helland; Sean Bredeson; Brett Garrick; Yevgeniy Gindin; Brad Sickler; Xing Wei; Kyle Seamon; Jingjing Jiang; Kian-Huat Lim; Matthew Holderfield; Elsa Quintana; Aparna Hegde; Zeena Salman; Alexander Starodub; Alexander Spira; Wungki Park; David S. Hong; Minal Barve; Meredith Pelster; David Sommerhalder; Salman R. Punekar; Ignacio Garrido-Laguna; Brian M. Wolpin; Anirban Maitra; W. Clay Gustafson; Steve Kelsey; Jacqueline A. M. Smith; Kevin K. Lin; Andrew J. Aguirre; Mallika Singh
errShare
errSave
Oncogenic Kras targeting with MRTX1133 or Daraxonrasib specifically synergize with anti-CTLA4 to promote anti-tumor immunity in pancreatic cancer
err2026-07-27
err0
errOAAI
errKrishnan K. Mahadevan; Ana S. Maldonado; Bingrui Li; Aaron A. Bickert; Adrian Kacperczyk-Perdyan; Shreyasee V. Kumbhar; Sujan Piya; Amari M. Sockwell; Sami J. Morse; Kent Arian; Hikaru Sugimoto; Shabnam Shalapour; David S. Hong; Timothy P. Heffernan; Anirban Maitra; Raghu Kalluri
errShare
errSave
Phase I study of bevacizumab and temsirolimus combination therapy in advanced malignancies: safety, efficacy, and ovarian cancer expansion
err2026-03-01
err0
errOAAI
errPiha-Paul, Sarina A.; Tseng, Chieh; Thompson, Emily; Stafford, R. Jason; Le, Hung; Kang, Lei; Fu, Siqing; Tsimberidou, Apostolia; Blumenschein, George; Ahnert, Jordi Rodon; Slopis, John M.; Hong, David; Naing, Aung; Meric-Bernstam, Funda; Ng, Chaan S.; Westin, Shannon; Sood, Anil K.
errShare
errSave
Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson
err2026-01-13
err0
errOAAI
errJeong Uk Lim; Heather Y. Lin; Lei Kang; Hung Le; Tin-Yun Tang; Stephane Champiat; Ecaterina Elena Dumbrava; Xiuning Le; Aung Naing; Sarina A. Piha-Paul; Jordi Rodon Ahnert; Apostolia Maria Tsimberidou; Timothy A. Yap; Siqing Fu; Funda Meric-Bernstam; David S. Hong
errShare
errSave
Predicting Benefit of Neoadjuvant Chemotherapy and Elective Nodal Irradiation in Pancreatic Adenocarcinoma: A Supervised Machine Learning Approach
err2025-12-01
err0
errOAAI
errHarada, Garrett K.; Park, Jino; Peterson, Nicholas; Munjal, Akul; Imagawa, David; Jutric, Zeljka; Dayyani, Farshid; Valerin, Jennifer; Hong, David S.; Seyedin, Steven N.
errShare
errSave
Phase Ia/b Multicenter Study of BPM31510IV Targeting Mitochondrial Metabolism/Warburg Effect as Monotherapy and Combination Chemotherapy in Solid Tumor Patients
err2025-12-01
err0
errOAAI
errSubbiah, Vivek; Yu, Peter P.; Sarangarajan, Rangaprasad; Kiebish, Michael A.; Rodrigues, Leonardo O.; Miller, Gregory M.; Akmaev, Viatcheslav R.; Luan, Shen; McCook, John P.; Tanna, Nikunj; Reilly, Tracey; Chen, Emily; Bussberg, Valerie; Ravipaty, Shobha; Vishnudas, Vivek K.; Gesta, Stephane; Lucius, David; Bruce, Can; Hazarika, Suwagmani; Lyng, Arianne; Klotz, Allison; Tolstikov, Vladimir; Stevens, Janice; Chua, Victoria S.; Granger, Elder; Tekumalla, Poornima K.; Benaim, Ely; Modur, Vijay; Rudoltz, Marc S.; Song, Paul Y.; Tagawa, Scott T.; Hendifer, Andrew; Chawla, Sant P.; Shah, Manish A.; Hong, David S.; Zinner, Ralph; Narain, Niven R.; Kundranda, Madappa N.
errShare
errSave
A Phase I Study of the Anti-CEACAM6 Antibody Tinurilimab (BAY 1834942) in Patients with Advanced Solid Tumors
err2025-06-04
err0
PREAI
errLillian L. Siu; David S. Hong; Wolf-Dietrich Döcke; Reimo Tetzner; Mark Trautwein; Charles Phelps; Joerg Willuda; Xiang Qing Yu; Hendrik Nogai; Melissa Johnson; Boon Cher Goh
errShare
errSave
Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancer
err2025-06-01
err0
PREAI
errD.S. Hong; R.-H. Xu; L. Shen; M.P. Dierselhuis; D. Orbach; R. McDermott; A. Italiano; M. Tahara; V. Bernard-Gauthier; N. Neu; C.E. Mussi; E. De La Cuesta; T.W. Laetsch; A. Drilon
errShare
errSave
Mesonephric-like adenocarcinoma of the female genital tract: Pathologic diagnosis, clinical outcomes, and novel therapeutics
err2025-06-01
err0
PREAI
errRing, Kari L.; Mills, Anne M.; Howitt, Brooke E.; Grisham, Rachel N.; Euscher, Elizabeth D.; Kim, Hyun-Soo; Klopp, Ann H.; Kolin, David L.; McCluggage, W. Glenn; Mirkovic, Jelena; Park, Kay J.; Aoun, Eliane; Awujo, Chika; So, Ji; Mo, Samuel C.; Ferri-Borgogno, Sammy; Hong, David S.; Hoang, Lien; Jazaeri, Amir A.; How, Jeffrey A.; Lu, Karen H.
errShare
errSave
Diet in adolescent and young adult patients with cancer and cancer survivors: a scoping review
err2025-05-24
err0
PREAI
errPropst, Casey L.; Sucholeiki, Robert Li; Chandra, Joya; Livingston, John A.; Roth, Michael E.; Hong, David S.; George, Goldy C.
errShare
errSave
Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer
err2025-05-01
err0
errOAAI
errQi, Changsong; Shen, Lin; Andre, Thierry; Chung, Hyun Cheol; Cannon, Timothy L.; Garralda, Elena; Italiano, Antoine; Rieke, Damian T.; Liu, Tianshu; Burcoveanu, Domnita-Ileana; Neu, Natascha; Mussi, Chiara E.; Xu, Rui-Hua; Hong, David S.; Drilon, Alexander; Berlin, Jordan
errShare
errSave
First-in-human, phase 1 dose escalation study of SL-279252, a hexameric PD1-Fc-OX40L fusion protein, in patients with advanced solid tumors and lymphoma
err2025-03-01
err0
PREAI
errJohnson, Melissa; Hong, David; Brana, Irene; Schoffski, Patrick; Galvao, Vladimir; Rangwala, Fatima; Ma, Bo; Hernandez, Robert; Kamat, Asha; Kato, Kazunobu; Schreiber, Taylor H.; Pandite, Lini; Siu, Lillian L.
errShare
errSave
Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study (vol 40, pg 290, 2022)
err2025-02-20
err0
errOAAI
errThein, Kyaw Z.; Karp, Daniel D.; Tsimberidou, Apostolia; Gong, Jing; Sulovic, Selma; Shah, Jatin; Milton, Denai R.; Hong, David S.; Janku, Filip; Mcquinn, Lacey; Stephen, Bettzy A.; Colen, Rivka; Carter, Brett W.; Yap, Timothy A.; Piha-Paul, Sarina A.; Fu, Siqing; Meric-Bernstam, Funda; Naing, Aung
errShare
errSave
Phase I study of BMS-986299, an NLRP3 agonist, as monotherapy and in combination with nivolumab and ipilimumab in patients with advanced solid tumors
err2025-01-16
err1
errOAAI
errNelson, Blessie E.; O'Brien, Shaun; Sheth, Rahul A.; Hong, David S.; Zhang, Xiaoping; Xu, Amy; Suryawanshi, Rasika; Mckinley, Derrick; Novosiadly, Ruslan D.; Piha-Paul, Sarina A.
errShare
errSave
Best Practice Guidelines for Use of Reference Points in Radiation Oncology Information Systems to Aggregate Longitudinal Dosimetric Data
err2024-11-01
err0
PREAI
errAlon Witztum; Younes Jourani; Emily Y. Hirata; Todd McNutt; Tony Tadic; Kristy K. Brock; David S. Hong; Michelle E. Howard; Andra V. Krauze; Peter A. Balter; Abigail L. Stockham; Elizabeth L. Covington; Ying Xiao; Richard Popple; Charles S. Mayo
errShare
errSave
Preliminary results from SEACRAFT-1: An open-label study of naporafenib with trametinib in patients with locally advanced unresectable or metastatic solid tumor malignancies with RAS Q61X mutations
err2024-10-01
err0
PREAI
errFontana, E.; Spira, A. I.; McKean, M.; Lee, J.; Chau, N.; Winquist, E.; Kim, I.; Hong, S. H.; Van Tine, B. A.; Fawole, A.; Shoemaker, R.; Cui, Y.; Sutton, R.; Antal, J. M.; Morris, S. R.; Hong, D. S.
errShare
errSave
Final results of IMPACT 2, a randomized study evaluating molecular profiling and targeted agents in metastatic cancer at MD Anderson Cancer Center
err2024-09-01
err0
PREAI
errTsimberidou, A. M.; Fu, S.; Hong, D. S.; Piha-Paul, S. A.; Naing, A.; Rodon, J.; Yap, T. A.; Karp, D.; Dumbrava, E. E.; Heymach, J. V.; Ajani, J. A.; Cartwright, C.; Beck, J.; Andersen, C.; Kahle, M.; Vining, D.; Ross, J. S.; Chao, C.; Berry, D. A.; Meric-Bernstam, F.
errShare
errSave
Hybridizing mechanistic modeling and deep learning for personalized survival prediction after immune checkpoint inhibitor immunotherapy
err2024-08-14
err1
errOAAI
errButner, Joseph D.; Dogra, Prashant; Chung, Caroline; Koay, Eugene J.; Welsh, James W.; Hong, David S.; Cristini, Vittorio; Wang, Zhihui
errShare
errSave
Phase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterations
err2024-07-31
err1
errOAAI
errPiha-Paul, Sarina A.; Tseng, Chieh; Leung, Cheuk Hong; Yuan, Ying; Karp, Daniel D.; Subbiah, Vivek; Hong, David; Fu, Siqing; Naing, Aung; Rodon, Jordi; Javle, Milind; Ajani, Jaffer A.; Raghav, Kanwal P.; Somaiah, Neeta; Mills, Gordon B.; Tsimberidou, Apostolia M.; Zheng, Xiaofeng; Chen, Ken; Meric-Bernstam, Funda
errShare
errSave